BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Synchronicity - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://syncconference.org
X-WR-CALDESC:Events for Synchronicity
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260319T104500
DTEND;TZID=America/New_York:20260319T121500
DTSTAMP:20260507T032749
CREATED:20260120T161153Z
LAST-MODIFIED:20260318T225133Z
UID:10000141-1773917100-1773922500@syncconference.org
SUMMARY:Findings From a Formative Evaluation of Hepatitis C Virus (HCV) Care and Treatment Co-Located in Non-Traditional Service Settings for People Who Use Drugs in New York State
DESCRIPTION:The co-location of HCV care and treatment services in non-traditional healthcare settings could improve HCV-related service uptake among people who inject drugs (PWID). However\, it is still relatively new in the United States compared to other parts of the world\, such as Australia and Europe. In 2018\, New York State (NYS) announced its plan to eliminate HCV as a public health problem by 2030. \nAs part of the initiative\, the state funded HCV Innovative Models of Care Initiative\, aiming to co-locate HCV treatment and care in non-traditional settings where PWID who are currently viremic would feel comfortable\, while receiving various services to remove barriers to initiating and completing HCV treatment. Three programs were funded under this initiative: a) Embedded primary care in the harm reduction drop-in center; b) Stationing a nurse practitioner in a SSP along with utilization of telemedicine for liver and substance use specialty care; and c) Integration of HCV care and treatment at substance use treatment clinics through on-site access to primary care or use of a mobile van. \nUnderstanding that the complexity and segmentation of the healthcare system can pose unique challenges to providing medical care in non-traditional settings in the United States\, a formative evaluation was conducted to assess the feasibility\, acceptability\, and effectiveness\, and whether enrolled clients completed the care cascade measured by four performance indicators: linkage to care\, treatment initiation\, treatment completion\, and achievement of SVR-12. Findings have supported the NYSDOH in making informed decisions about program continuation and potential statewide adaptation.
URL:https://syncconference.org/agenda/findings-from-a-formative-evaluation-of-hepatitis-c-virus-hcv-care-and-treatment-co-located-in-non-traditional-service-settings-for-people-who-use-drugs-in-new-york-state/
LOCATION:Terrace
CATEGORIES:Track Session
ATTACH;FMTTYPE=image/jpeg:https://syncconference.org/wp-content/uploads/2026/01/TrackHero-HCV.jpg
END:VEVENT
END:VCALENDAR